APPLICATION
ANDA207014
TYPE
ANDA
ORIGINAL APPROVAL
2018-03-19
LATEST ACTION
2020-02-10
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued
Products
CYCLOPHOSPHAMIDEDiscontinued
CYCLOPHOSPHAMIDE 50MG · CAPSULE · ORAL
CYCLOPHOSPHAMIDEDiscontinued
CYCLOPHOSPHAMIDE 25MG · CAPSULE · ORAL
Approval history
2020-02-10Labeling · Supplement 1 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.